Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis
Liu, Xia2; Zhong, Fang1; Tang, Xu-long2; Lian, Fu-lin2; Zhou, Qiao1; Guo, Shan-mai1; Liu, Jia-fu3; Sun, Peng2; Hao, Xu1; Lu, Ying1
刊名ACTA PHARMACOLOGICA SINICA
2014-05
卷号35期号:5页码:697-706
关键词Cordyceps sinensis chronic kidney disease liver injury heart injury metabolomics nuclear magnetic resonance traditional Chinese medicine
ISSN号1671-4083
DOI10.1038/aps.2013.186
文献子类Article
英文摘要Aim: To test the hypothesis that the traditional Chinese medicine Cordyceps sinensis could improve the metabolic function of extrarenal organs to achieve its anti-chronic kidney disease (CKD) effects. Methods: Male SD rats were divided into CKD rats (with 5/6-nephrectomy), CKD rats treated with Cordyceps sinensis (4 mg.kg(-1).d(-1), po), and sham-operated rats. After an 8-week treatment, metabolites were extracted from the hearts and livers of the rats, and then subjected to H-1-NMR-based metabolomic analysis. Results: Oxidative stress, energy metabolism, amino acid and protein metabolism and choline metabolism were considered as links between CKD and extrarenal organ dysfunction. Within the experimental period of 8 weeks, the metabolic disorders in the liver were more pronounced than in the heart, suggesting that CKD-related extrarenal organ dysfunctions occurred sequentially rather than simultaneously. Oral administration of Cordyceps sinensis exerted statistically significant rescue effects on the liver and heart by reversely regulating levels of those metabolites that are typically perturbed in CKD. Conclusion: Oral administration of Cordyceps sinensis significantly attenuates the liver and heart injuries in CKD rats. The H-1 NMR-based metabolomic approach has provided a systematic view for understanding of CKD and the drug treatment, which can also be used to elucidate the mechanisms of action of other traditional Chinese medicines.
资助项目National Natural Science Foundation of China[30900662] ; Shanghai Foundation for Development of Science and Technology[08411965600] ; "100 Talents Program" of the Chinese Academy of Sciences[00000000]
WOS关键词CHRONIC-RENAL-FAILURE ; UPLC Q-TOF/HSMS/MSE ; OXIDATIVE STRESS ; URINARY METABONOMICS ; H-1-NMR SPECTROSCOPY ; HEPATIC GLUTATHIONE ; PORIA-COCOS ; Q-TOF/MS ; TAURINE ; TISSUE
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
CSCD记录号CSCD:5142660
出版者ACTA PHARMACOLOGICA SINICA
WOS记录号WOS:000335447000014
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/277102]  
专题分析化学研究室
药物安全性评价中心
通讯作者Wang, Wei-ming
作者单位1.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200025, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 201203, Peoples R China;
3.Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA
推荐引用方式
GB/T 7714
Liu, Xia,Zhong, Fang,Tang, Xu-long,et al. Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis[J]. ACTA PHARMACOLOGICA SINICA,2014,35(5):697-706.
APA Liu, Xia.,Zhong, Fang.,Tang, Xu-long.,Lian, Fu-lin.,Zhou, Qiao.,...&Zhang, Nai-xia.(2014).Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.ACTA PHARMACOLOGICA SINICA,35(5),697-706.
MLA Liu, Xia,et al."Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis".ACTA PHARMACOLOGICA SINICA 35.5(2014):697-706.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace